Haptoglobin Phenotype and Levels in Type 2 Diabetes and Effects of Fenofibrate

被引：0
|
作者：
Januszewski, Andrzej S.
Young, Hayden K.
Li, Liping
Oconnell, Rachel L.
Lyons, Timothy
Kelly, Clare B.
Sullivan, David
Scott, Russell
Keech, Anthony C.
Jenkins, Alicia
机构：
来源：
DIABETES | 2019年 / 68卷
基金：
英国医学研究理事会;
关键词：
D O I：
10.2337/db19-139-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
139-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate
    Januszewski, Andrzej S.
    Young, Hayden K.
    Ong, Kwok-Leung
    Li, Liping
    O'Connell, Rachel L.
    Lyons, Timothy J.
    Kelly, Clare
    Zaharieva, Dessi P.
    Sullivan, David R.
    Scott, Russell S.
    Keech, Anthony C.
    Jenkins, Alicia J.
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (11) : 1663 - 1668
  • [2] Relationship of haptoglobin phenotype and levels with sight-threatening diabetic retinopathy in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in diabetes (FIELD) substudy
    Ong, Kwok Leung
    Januszewski, Andrzej S.
    Francis, Habib
    O'Connell, Rachel L.
    Mangani, Abubakar
    Li, Liping
    Colman, Peter G.
    Sullivan, David R.
    Scott, Russell S.
    Jenkins, Alicia J.
    Keech, Anthony C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 222
  • [3] Atherogenic lipoprotein phenotype in type 2 diabetes: Reversal with micronised fenofibrate
    Feher, MD
    Caslake, M
    Foxton, J
    Cox, A
    Packard, CJ
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 1999, 15 (06) : 395 - 399
  • [4] Haptoglobin (Hp) Levels and Phenotype Are Unrelated to Severe Retinopathy in Type 2 Diabetes, but Lower Hp Reductions by Fenofibrate Are Associated with Greater Retinopathy Benefit-A FIELD Trial Study
    Ong, Kwok Leung
    Januszewski, Andrzej S.
    Francis, Habib
    Mangani, Abubakar Siddiq O.
    O'Connell, Rachel L.
    Jenkins, Alicia
    Keech, Anthony C.
    DIABETES, 2024, 73
  • [5] Haptoglobin 2-2 phenotype is a risk factor for type 2 diabetes in Ghana
    Quaye, IK
    Ababio, G
    Amoah, AG
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2006, 13 (02) : 90 - 94
  • [6] The Influence of Haptoglobin Phenotype on Carotid Macroangiopathy in Patients With Type 2 Diabetes Mellitus
    Sato, Takao
    Kameyama, Tomoki
    Inoue, Hiroshi
    CIRCULATION, 2013, 128 (22)
  • [7] Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus
    Ametov, A. S.
    Prudnikova, M. A.
    DIABETES MELLITUS, 2014, 17 (04): : 43 - 50
  • [8] Haptoglobin phenotype and gestational diabetes
    Mustafa, S
    Schneider, B
    Vukovich, T
    Esterbauer, H
    Prikoszovich, T
    Wagner, O
    Winzer, C
    Kautzky-Willer, A
    DIABETES CARE, 2004, 27 (09) : 2103 - 2107
  • [9] Haptoglobin phenotype and gestational diabetes
    Kautzky-Willer, A
    Mustafa, S
    Winzer, C
    Vukovich, T
    DIABETOLOGIA, 2004, 47 : A339 - A339
  • [10] Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus
    Pavlicek, V.
    DIABETOLOGE, 2011, 7 (02): : 115 - 116
12345